Mucous membranes are the entry points for infections and form the body’s natural barrier when it comes into contact with the external environment. These membranes can be found in the respiratory, digestive, urogenital tracts, and the eyes. In today’s modern “sterile” world, we lack microbial stimuli, leading to reduced immune resistance.
Immune stimulation and modulation of excessive inflammation are achieved through microbial signals using original NEXARS strains of human probiotics and microscopic fungi (see GenBank link).
The award-winning product was successfully validated in practice during the 2020–2022 pandemic.
This achievement in 2022 is confirmed by a statement from Mgr. Jiří Prokop, Ph.D., Head of Health Services and Ergonomics at ŠKODA AUTO a.s., regarding the improved IMUNOCOMPLEX 2020+ product:
‘We evaluated this programme as effective because it helped us reduce the impact of the pandemic, achieve high employee compliance and provide a basis for the long-term, cost-effective management of the infectious disease, SARS-CoV-2.’
Best Biotechnology Product Award